To amend the Federal Food, Drug, and Cosmetic Act to authorize requiring the manufacturers of a covered device to disclose to a patient all patient-specific data that is recorded or transmitted by the device and accessible to the manufacturer, and for other purposes.
About This Bill
Committee
Latest Action · December 12, 2024
Referred to the House Committee on Energy and Commerce.